Expanding access to naloxone: a review of distribution strategies
- Collection:
- Health Policy and Services Research
- Series Title(s):
- Issue brief (Leonard Davis Institute of Health Economics)
- Author(s):
- Weiner, Janet, author Murphy, Sean , author Behrends, Czarina, author
- Contributor(s):
- Center for Health Economics of Treatment Interventions for Substance Use Disorder, HCV, and HIV, issuing body. Leonard Davis Institute of Health Economics, issuing body.
- Publication:
- Philadelphia, PA : Leonard Davis Institute of Health Economics, May 2019
- Language(s):
- English
- Format:
- Text
- Subject(s):
- Drug Overdose -- drug therapy Drug Overdose -- prevention & control Health Services Accessibility Naloxone -- supply & distribution Naloxone -- therapeutic use Opioid-Related Disorders -- drug therapy Community Health Services Emergency Responders Nonprescription Drugs Opioid-Related Disorders -- epidemiology Pharmacies Humans United States
- Genre(s):
- Technical Report
- Abstract:
- Amidst an ongoing opioid crisis that claimed 47,600 lives in 2017, increasing the availability of the rescue medication naloxone is a high priority. Naloxone reverses an opioid overdose when given intranasally or intramuscularly. But to be effective, naloxone must be available at the time of overdose. The U.S. Department of Health and Human Services identifies naloxone distribution as one of the top three strategies for addressing the opioid epidemic. Last year, the U.S. Surgeon General called naloxone a "safe antidote" to a suspected overdose, and urged more individuals to carry naloxone, including family, friends, community members, and those who are personally at risk. Naloxone distribution to laypeople can save a life when first responders are not immediately available, or when people witnessing overdoses are unwilling or unable to call 911. Naloxone is increasingly available through some pharmacies under a standing order; however, even when available, cost and stigma barriers persist. This Issue Brief reviews recent evidence on the outcomes and cost-effectiveness of naloxone distribution strategies in community, pharmacy, and other health care settings.
- Copyright:
- Reproduced with permission of the copyright holder. Further use of the material is subject to CC BY license. (More information)
- Extent:
- 1 online resource (1 PDF file (7 pages)).
- NLM Unique ID:
- 101750194 (See catalog record)
- Permanent Link:
- http://resource.nlm.nih.gov/101750194